Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis

Ítems similars

• Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
  per: Freeman, Hugh J
  Publicat: (2013)
• Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
  per: Suzuki, Yasuo, et al.
  Publicat: (2017)
• Adalimumab in the Treatment of Moderate-to-Severe Ulcerative Colitis: ULTRA 2 Trial Results
  Publicat: (2013)
• Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
  per: Suzuki, Yasuo, et al.
  Publicat: (2013)
• Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
  per: Suzuki, Yasuo, et al.
  Publicat: (2017)